David Summa

Président chez IONpath, Inc.

Profil

David W.
Summa is currently the Executive Chairman at IONpath, Inc. since 2023 and an Advisor at Peaxy, Inc. since 2016.
Previously, he served as the President & Chief Executive Officer at Mendel Biotechnology, Inc. from 1999 to 2002.
He also held positions as a Director at Monsanto Co., Director at Sequoia Pharmaceuticals, Inc., Director at Acumen Pharmaceuticals, Inc., Director at Agrivida, Inc., Director at Alliance of Chief Executives LLC from 2020 to 2021, and Chief Business Officer at Mascoma Corp.
He was a Vice President at Halio, Inc. in 2012.
Prior to that, he worked as a Partner at McKinsey & Co., Inc. from 1989 to 1996.
Additionally, he served as the Executive Vice President at Kiverdi, Inc. in 2015 and as an Operating Partner at Genoa Ventures LLC from 2021 to 2023.
Mr. Summa obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology in 1981 and 1985, respectively.

Postes actifs de David Summa

Sociétés	Poste	Début
Peaxy, Inc.	Consultant / Advisor	01/02/2016
IONpath, Inc.	Président	06/12/2023

Anciens postes connus de David Summa

Sociétés	Poste	Fin
Genoa Ventures LLC	Private Equity Investor	01/11/2023
Alliance of Chief Executives LLC	Directeur/Membre du Conseil	02/12/2021
Kiverdi, Inc.	Private Equity Investor	02/11/2015
Halio, Inc.	Private Equity Investor	02/10/2012
ACUMEN PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	02/01/2008